Furthermore, SHAP results reveal that higher expression levels of TSPYL5, ATP5E, CA9, NUP210, SLC37A1, ARIH1, PSMD7, UBQLN1, PRAME, and UBE2T are associated with an increased risk of BC metastasis. This evidence concerns the gene UBE2T and breast cancer.